{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:11:42Z","timestamp":1792905102174,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93388-5","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:13:00Z","timestamp":1747224780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological inhibition of hypoxia induced acidosis employing a CAIX inhibitor sensitizes gemcitabine resistant PDAC cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Jeevan","family":"Ghosalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Sonawane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Achrekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"93388_CR1","unstructured":"Cancer Stat Facts: Pancreatic Cancer. Accessed on April 2024; https:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html"},{"key":"93388_CR2","doi-asserted-by":"publisher","unstructured":"Roth, M.T, Cardin, D. B. & Berlin J. D. Recent advances in the treatment of pancreatic cancer. F1000Res. 9, F1000 Faculty Rev-131. https:\/\/doi.org\/10.12688\/f1000research.21981.1 (2020).","DOI":"10.12688\/f1000research.21981.1"},{"issue":"22","key":"93388_CR3","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.3390\/cancers15225307","volume":"15","author":"TN Huynh","year":"2023","unstructured":"Huynh, T. N. et al. The unmet needs of pancreatic cancer carers are associated with anxiety and depression in patients and carers. Cancers 15(22), 5307. https:\/\/doi.org\/10.3390\/cancers15225307 (2023).","journal-title":"Cancers"},{"key":"93388_CR4","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.3748\/wjg.v27.i28.4582","volume":"27","author":"M Estaras","year":"2021","unstructured":"Estaras, M. & Gonzalez, A. Modulation of cell physiology under hypoxia in pancreatic cancer. World J. Gastroenterol. 27, 4582\u20134602. https:\/\/doi.org\/10.3748\/wjg.v27.i28.4582 (2021).","journal-title":"World J. Gastroenterol."},{"key":"93388_CR5","doi-asserted-by":"publisher","first-page":"905768","DOI":"10.3389\/fimmu.2022.905768","volume":"13","author":"N Tatari","year":"2022","unstructured":"Tatari, N. et al. Dual antigen T cell engagers targeting CA9 as an effective immunotherapeutic modality for targeting CA9 in solid tumors. Front. Immunol. 13, 905768. https:\/\/doi.org\/10.3389\/fimmu.2022.905768 (2022).","journal-title":"Front. Immunol."},{"key":"93388_CR6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3390\/cancers12082005","volume":"12","author":"S Strapcova","year":"2020","unstructured":"Strapcova, S. et al. Clinical and pre-clinical evidence of carbonic anhydrase IX in pancreatic cancer and its high expression in pre-cancerous lesions. Cancers 12, 2005. https:\/\/doi.org\/10.3390\/cancers12082005 (2020).","journal-title":"Cancers"},{"key":"93388_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","volume":"157","author":"PC McDonald","year":"2019","unstructured":"McDonald, P. C. et al. Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic cancer cells with activated KRAS in response to hypoxia. Gastroenterology 157, 823\u2013837. https:\/\/doi.org\/10.1053\/j.gastro.2019.05.004 (2019).","journal-title":"Gastroenterology"},{"key":"93388_CR8","doi-asserted-by":"publisher","first-page":"13405","DOI":"10.3390\/ijms222413405","volume":"2","author":"S Kalinin","year":"2021","unstructured":"Kalinin, S. et al. Carbonic anhydrase IX inhibitors as candidates for combination therapy of solid tumors. Int. J. Mol. Sci. 2, 13405. https:\/\/doi.org\/10.3390\/ijms222413405 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"93388_CR9","first-page":"1761","volume":"10","author":"M Pa\u0161kevi\u010di\u016bt\u0117","year":"2020","unstructured":"Pa\u0161kevi\u010di\u016bt\u0117, M. & Petrikait\u0117, V. Application of carbonic anhydrase inhibitors to increase the penetration of doxorubicin and its liposomal formulation into 2D and 3D triple negative breast cancer cell cultures. Am. J. Cancer Res. 10, 1761\u20131769 (2020).","journal-title":"Am. J. Cancer Res."},{"key":"93388_CR10","unstructured":"Improving Tumor Oxygenation in Cervical Cancer with Methazolamide. ClinicalTrials.gov ID NCT00257829, Sponsor, University of California, Irvine."},{"key":"93388_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nbd.2015.11.006","volume":"86","author":"S Fossati","year":"2016","unstructured":"Fossati, S. et al. The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain. Neurobiol. Dis. 86, 29\u201340. https:\/\/doi.org\/10.1016\/j.nbd.2015.11.006 (2016).","journal-title":"Neurobiol. Dis."},{"key":"93388_CR12","doi-asserted-by":"publisher","first-page":"15370","DOI":"10.1038\/s41598-023-42721-x","volume":"13","author":"T Sun","year":"2023","unstructured":"Sun, T. et al. Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA. Sci. Rep. 13, 15370. https:\/\/doi.org\/10.1038\/s41598-023-42721-x (2023).","journal-title":"Sci. Rep."},{"key":"93388_CR13","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.2337\/dc14-1038","volume":"37","author":"RW Simpson","year":"2014","unstructured":"Simpson, R. W. et al. Efficacy and safety of oral methazolamide in patients with type 2 diabetes: A 24-week, placebo-controlled, double-blind study. Diabetes Care. 37, 3121\u20133123. https:\/\/doi.org\/10.2337\/dc14-1038 (2014).","journal-title":"Diabetes Care."},{"key":"93388_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/ijms25010610","volume":"25","author":"K Rump","year":"2024","unstructured":"Rump, K. et al. Methazolamide reduces the AQP5 mRNA expression and immune cell migration\u2014A new potential drug in sepsis therapy?. Int. J. Mol. Sci. 25, 610. https:\/\/doi.org\/10.3390\/ijms25010610 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"93388_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1113\/EP088058","volume":"105","author":"LJ Teppema","year":"2020","unstructured":"Teppema, L. J. et al. Influence of methazolamide on the human control of breathing: A comparison to acetazolamide. Exp. Physiol. 105, 293\u2013301. https:\/\/doi.org\/10.1113\/EP088058 (2020).","journal-title":"Exp. Physiol."},{"key":"93388_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.cmet.2022.01.008","volume":"34","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry. Cell. Metab. 34, 424\u2013440. https:\/\/doi.org\/10.1016\/j.cmet.2022.01.008 (2022).","journal-title":"Cell. Metab."},{"key":"93388_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/OPTH.S41540","volume":"7","author":"AA Aref","year":"2013","unstructured":"Aref, A. A., Sayyad, F. E., Ayres, B. & Lee, R. K. Acute bilateral angle closure glaucoma induced by methazolamide. Clin. Ophthalmol. 7, 279\u2013282. https:\/\/doi.org\/10.2147\/OPTH.S41540 (2013).","journal-title":"Clin. Ophthalmol."},{"key":"93388_CR18","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.1038\/s41598-023-32627-z","volume":"13","author":"V Sonawane","year":"2023","unstructured":"Sonawane, V., Ghosalkar, J., Achrekar, S. & Joshi, K. Ketorolac modulates Rac-1\/HIF-1\u03b1\/DDX3\/\u03b2-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma. Sci. Rep. 13, 5659. https:\/\/doi.org\/10.1038\/s41598-023-32627-z (2023).","journal-title":"Sci. Rep."},{"key":"93388_CR19","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.3390\/cancers14133198","volume":"14","author":"J Ghosalkar","year":"2022","unstructured":"Ghosalkar, J. et al. Prostate apoptosis response-4 (Par-4): A novel target in pyronaridine-induced apoptosis in glioblastoma (GBM) cells. Cancers 14, 3198. https:\/\/doi.org\/10.3390\/cancers14133198 (2022).","journal-title":"Cancers"},{"key":"93388_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495\u2013501. https:\/\/doi.org\/10.1038\/nature14169 (2015).","journal-title":"Nature"},{"key":"93388_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature11547","volume":"49","author":"AV Biankin","year":"2012","unstructured":"Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 49, 399\u2013405. https:\/\/doi.org\/10.1038\/nature11547 (2012).","journal-title":"Nature"},{"key":"93388_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.6004\/jnccn.2020.7641","volume":"19","author":"M Gupta","year":"2021","unstructured":"Gupta, M. et al. Targeting the NTRK fusion gene in pancreatic acinar cell carcinoma: A case report and review of the literature. J. Natl. Compr. Canc. Netw. 19, 10\u201315. https:\/\/doi.org\/10.6004\/jnccn.2020.7641 (2021).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"93388_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-024-01808-1","volume":"5","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct. Target Ther. 5, 113. https:\/\/doi.org\/10.1038\/s41392-024-01808-1 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"93388_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1377\/hlthaff.2022.01083","volume":"42","author":"W Greenblatt","year":"2023","unstructured":"Greenblatt, W., Gupta, C. & Kao, J. Drug repurposing during the COVID-19 pandemic: Lessons for expediting drug development and access. Health Affi. 42, 424\u2013432. https:\/\/doi.org\/10.1377\/hlthaff.2022.01083 (2023).","journal-title":"Health Affi."},{"key":"93388_CR25","first-page":"3552","volume":"41","author":"E Gudmundsd\u00f3ttir","year":"2000","unstructured":"Gudmundsd\u00f3ttir, E. et al. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension. Invest. Ophthalmol. Vis. Sci. 41, 3552\u20133554 (2000).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"93388_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071723","author":"J Haapasalo","year":"2020","unstructured":"Haapasalo, J., Nordfors, K., Haapasalo, H. & Parkkila, S. The expression of carbonic anhydrases II, IX and XII in brain tumors. Cancers https:\/\/doi.org\/10.3390\/cancers12071723 (2020).","journal-title":"Cancers"},{"key":"93388_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/molecules23051045","volume":"23","author":"S Singh","year":"2018","unstructured":"Singh, S., Lomelino, C. L., Mboge, M. Y., Frost, S. C. & McKenna, R. Cancer drug development of carbonic anhydrase inhibitors beyond the active site. Molecules 23, 1045. https:\/\/doi.org\/10.3390\/molecules23051045 (2018).","journal-title":"Molecules"},{"key":"93388_CR28","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.3390\/cancers14102486","volume":"14","author":"T Koltai","year":"2022","unstructured":"Koltai, T. et al. Resistance to gemcitabine in pancreatic ductal adenocarcinoma: A physiopathologic and pharmacologic review. Cancers 14, 2486. https:\/\/doi.org\/10.3390\/cancers14102486 (2022).","journal-title":"Cancers"},{"key":"93388_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6214838","author":"ME Cameron","year":"2018","unstructured":"Cameron, M. E., Yakovenko, A. & Trevino, J. G. Glucose and lactate transport in pancreatic cancer: Glycolytic metabolism revisited. J Oncol. https:\/\/doi.org\/10.1155\/2018\/6214838 (2018).","journal-title":"J Oncol."},{"key":"93388_CR30","doi-asserted-by":"publisher","first-page":"16832","DOI":"10.18632\/oncotarget.4160","volume":"6","author":"R Cohen","year":"2015","unstructured":"Cohen, R. et al. Targeting cancer cell metabolism in pancreatic adenocarcinoma. Oncotarget 6, 16832\u201316847. https:\/\/doi.org\/10.18632\/oncotarget.4160 (2015).","journal-title":"Oncotarget"},{"key":"93388_CR31","doi-asserted-by":"publisher","first-page":"113860","DOI":"10.1016\/j.biopha.2022.113860","volume":"156","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei, S. et al. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response. Biomed. Pharmacother. 156, 113860. https:\/\/doi.org\/10.1016\/j.biopha.2022.113860 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"93388_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.15283\/ijsc20097","volume":"3","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q., Han, Z., Zhu, Y., Chen, J. & Li, W. The role and specific mechanism of OCT4 in cancer stem cells: A review. Int. J. Stem Cells 3, 312\u2013325. https:\/\/doi.org\/10.15283\/ijsc20097 (2020).","journal-title":"Int. J. Stem Cells"},{"key":"93388_CR33","doi-asserted-by":"publisher","first-page":"108879","DOI":"10.1016\/j.isci.2024.108879","volume":"27","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model. iScience 27, 108879. https:\/\/doi.org\/10.1016\/j.isci.2024.108879 (2024).","journal-title":"iScience"},{"issue":"3","key":"93388_CR34","doi-asserted-by":"publisher","first-page":"e24670","DOI":"10.1016\/j.heliyon.2024.e24670","volume":"10","author":"N Jan","year":"2024","unstructured":"Jan, N. et al. Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology. Heliyon 10(3), e24670. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24670 (2024).","journal-title":"Heliyon"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93388-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93388-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93388-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:13:07Z","timestamp":1747224787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93388-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93388"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93388-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with German Animal Welfare act (Tierschutzgesetz) Oncotest (P441K and May 2016) for studies involving animals. And, in accordance with Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"16782"}}